Effectiveness of Extended-Duration Transdermal Nicotine Therapy

Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial.

BACKGROUND Tobacco dependence is a chronic, relapsing condition that may require extended treatment. OBJECTIVE To assess whether extended-duration transdermal nicotine therapy increases abstinence from tobacco more than standard-duration therapy in adult smokers. DESIGN Parallel randomized, placebo-controlled trial from September 2004 to February 2008. Participants and all research personne...

The pros and cons of transdermal nicotine therapy.

OBJECTIVE To review current knowledge of the efficacy, safety and cost of transdermal nicotine therapy for smoking cessation. DATA SOURCES AND STUDY SELECTION 1. Published and unpublished reports of randomised, double-blind trials of at least 12 weeks' duration, in smokers motivated to cease smoking, identified by a search of the MEDLINE database, article and book bibliographies, Current cont...

Side effects of transdermal nicotine patches.

Correlates of adherence with transdermal nicotine.

This correlational study examined the adherence rates of transdermal nicotine (TN) use among a population of males and females 18 years of age and older (N = 619) who received varying levels of behavioral intervention. Rates of patch adherence were assessed for demographic (e.g., gender, ethnicity, and age), income-, smoking- [e.g., baseline carbon monoxide (CO), nicotine dependence, and follow...

A comparison of measures used to assess effectiveness of the transdermal nicotine patch at 1 year.

This study examines outcome measures of abstinence among studies reporting 12-month outcomes of the nicotine transdermal patch using different measures of effectiveness. This was achieved by reviewing published randomized controlled studies reporting 1-year abstinence rates of the nicotine transdermal patch. Comparisons are made across studies of three outcome measures used to report abstinence...